Prediction of Structure Activity Relationship (SAR) of Lactobacillus plantarum DA2 content for Cholesterol Reduction Treatment

Author:

Abdullah Dessy1,Poddar Sandeep1,Purnama Dewi Nadia2,Teti Vani Ade2

Affiliation:

1. Lincoln University College, Wisma Lincoln, 12-18, Jalan SS 6/12, 47301 Petaling Jaya, Selangor, Malaysia.

2. Faculty of Medical, Baiturrahmah University, 49HM+VCJ, Jalan Raya By Pass, AiePacah, Koto Tangah, Aie Pacah, Kec. Koto Tangah, Kota Padang, Sumatera Barat 25586, Indonesia.

Abstract

Cholesterol is a chemical that is naturally created by the liver but can also be present in animal-based meals like meat and milk. Cholesterol is required by the body for the formation of healthy cells, the production of several hormones, and the production of vitamin D. Although cholesterol is necessary for the body, high levels can be harmful to one's health, hence therapy to lower cholesterol levels using natural products or the aid of bacterial metabolism is required. Lactobacillus plantarum 2DA is a lactic acid bacterium that has potential as a probiotic, so further analysis is needed on its ability as a therapy to reduce cholesterol through a bioinformatics approach. The method used in this research is to search for bacterial secondary metabolites by studying literature from published journals. Each compound is then searched in the PubChem database for its canonical structure and isomeric SMILE (simplified molecular-input line-entry system) and secondary metabolites in bacteria from the literature study were analyzed for potential using WAY2DRUG PASS prediction (http://www.pharmaexpert. ru/passonline/predict.php) as a cholesterol-lowering treatment. The results of the study based on the prediction of the SAR Way2 Drug Pass Server seen in the Probability To Be Active (Pa) values obtained 0.45, 0.49 and 0.37 for anti-hypercholesterolemic, cholesterol antagonist and cholesterol oxidase inhibitors. From the results obtained, it can be recommended that Lactobacillus plantarum 2DA can be further researched in vivo for cholesterol-lowering therapy.

Publisher

A and V Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3